Pharmacovigilance-Market

Pharmacovigilance Market Is Set To Reach $15,259.8 Million by 2030 To receive free sample pages of this report @ https://Clickbait/381VGgH The global pharmacovigilance market is expected to reach $15,259.8 million by 2030 from $6,724.2 million in 2021, growing at a CAGR of 9.5% during 2021–2030. In 2021, based on therapeutic area, the oncology category held a 27% share. Due to the side-effects of cancer drugs, monitoring their safety is extremely important. In this regard, pharmacovigilance aids in detecting, managing, and even preventing adverse drug reactions and limiting the requirement for needless medical prescriptions. The high patient compliance for drug usage, rising concerns regarding drug safety, and growing incidence of toxicity and ADRs propel the pharmacovigilance market growth. Moreover, non-government and government organizations are focusing on drug efficacy and safety, which is compelling drug developers and entities conducting medical trials to avail of pharmacovigilance services.